Advisors Preferred’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Advisors Preferred's DGX Position: Q2 2023 in Review
Advisors Preferred sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 3,373 shares — an estimated $481K sold.
Advisors Preferred first reported a position in DGX in Q2 2022 and held it in 4 quarters. The position peaked at $636K in Q2 2022. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Advisors Preferred reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
- Advisors Preferred sold 3,373 Quest Diagnostics shares in Q2 2023, an estimated $481K.
- Advisors Preferred first reported a position in Quest Diagnostics in Q2 2022 and held it in 4 quarters.
- Advisors Preferred's Quest Diagnostics position peaked at $636K in Q2 2022.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Advisors Preferred's 13F filing for Q2 2023, filed 4 Aug 2023.